Business
Ocumetics Announces Appointment of Raymond Marks to Board of Directors
(TheNewswire)   Calgary, Alberta – TheNewswire - February 24, 2026 - Ocumet...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Announces Appointment of Raymond Marks to Board of Directors\n(TheNewswire)\n\n\n  \n\n\n\n\n\nCalgary, Alberta – TheNewswire - February 24, 2026 -\nOcumetics Technology Corp. (“Ocumetics” or the “Company”)\n(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation\nophthalmic technology, is pleased to announce\nthat Raymond Marks has been appointed to its Board of\nDirectors.\n\n\nRaymond Marks was instrumental in the early fundraising\nefforts of the Company and participated in meetings that resulted in\nOcumetics securing financing for its initial public listing by reverse\ntakeover. \n\n\nHe has over 50 years of experience as an entrepreneur,\nowner, operator and manager across a variety of industries including\nthe resources and industrial sectors. Throughout his career, Mr. Marks\nhas worked with many such companies and has worked with growing\ncompanies to secure millions in financing for their strategic\ninitiatives.\n\n\nMr. Marks previously co-founded Tudor Gold Corp.\n(TSXV:TUD) and served as executive Vice President, and a director of\nTudor from February 2016 until October 2018. Mr. Marks later assisted\nin the formation of Hanstone Capital Corporation which later became\nHanstone Gold Corp. where he served as President and Chief Executive\nOfficer from October 2018 until October 2025. Mr. Marks helped secure\nover $16 million in financing for the two companies. \n\n\n“We welcome Mr. Marks to the board of Ocumetics and\nlook forward to benefiting from his capital markets experience and\nassistance with our next stage of fundraising,” says Dean Burns,\nPresident and CEO of Ocumetics. \n\n\nAbout Ocumetics \n\n\nOcumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)\nis a Canadian research and product development company that is\ndedicated to developing advanced vision correction solutions that\nenhance the quality of life for patients.  Through innovative\nresearch and development, Ocumetics aims to transform the field of\nophthalmology with state-of-the-art intraocular lenses and other\nvision-enhancing technologies.\n\n\nOcumetics is in the first-in-human early feasibility\nstudy phase of a game-changing technology for the ophthalmic industry.\n Ocumetics has developed an intraocular lens that fits within the\nnatural len...